A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
NCT00679718 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2015-08-27
Summary
To evaluate the efficacy and safety of INS365 Ophthalmic Solution when applied topically in patients with moderate to severe dry eye disease.
Conditions
Interventions
- DRUG
-
diquafosol tetrasodium (INS365) ophthalmic solution
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Director · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2000-07-31
- Completion
- 2000-07-31
More Related Trials
-
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
NCT00600288 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
NCT00758784 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
NCT00831662 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
NCT03764735 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
NCT01768312 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
NCT04735393 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
NCT06493604 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
NCT06389214 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Assess Subjects With Dry Eye Disease.
NCT04971031 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
NCT02121301 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
NCT06766357 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
NCT06370039 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Rebamipide Eye Drops to Treat Dry Eye
NCT00201955 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01118754 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT06537349 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00349583 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center Study Subjects With Dry Eye Syndrome
NCT01745887 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Rebamipide Eye Drops to Treat Dry Eye
NCT00201981 ·Status: COMPLETED ·Phase: PHASE3
-
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 ·Status: COMPLETED ·Phase: PHASE2